##common.pageHeaderLogo.altText##

Vol. 3 No. 2 (2023)

The Health Related Quality Of Life among Patients with Medication Overuse Headache: One Year University Headache Center Experience

Clinical Medicine And Health Research Journal, Vol. 3 No. 2 (2023), 29 March 2023 , Page 336-345
https://doi.org/10.18535/cmhrj.v3i2.135

Abstract

Background: The negative impact of medication overuse headache (MOH) on the quality of life (QoL) of the patient is undoubted.


Objective: The aim of this study was to identify clinical and headache related parameters that directly affect HRQoL of MOH patients.


Patients and Methods: 183 patients (111 men and 72 women) firstly diagnosed as having MOH and 81 healthy subjects (22 men and 59 women) in control group (CG) were enrloed in this study. The age of the study subjects range from 18 to 71 years. HRQoL was assessed using a Short Form - 36 questionnaire (SF-36), measuring its Physical Composite Score (PCS), Mental Composite Score (MCS) and Total score (TS).


Results: All HRQoL domeins (PCS, MCS, TS) were lower in MOH compared to the CG (p <0.001). In MOH, the depression itself is a risk factor for all aspects of HRQoL, for PCS (B = -0.70, 95% CI -1.32 - - 0.08, p = 0.027); for MCS (B = -0.71, 95% CI -1.14 - - 0.29, p = 0.001); for TS (B = -0.69, 95% CI -1.16 - - 0.22, p = 0.005)), with female gender being an associated risk factor only for PCS (B = -15.47, 95% CI -26.79 - - 4.14, p = 0.008). The results did not find a predictive role of anxiety, stress, and ruminative style of thinking for HRQoL in MOH patients (p>0.05).


Conclusions: Screening for depression among MOH patients and its treatment could be useful for improving their HRQoL

How to Cite

Srdjan, L. ., Dejan, A. ., Dimos, M. ., & Radomir, D. . (2023). The Health Related Quality Of Life among Patients with Medication Overuse Headache: One Year University Headache Center Experience. Clinical Medicine And Health Research Journal, 3(2), 336–345. https://doi.org/10.18535/cmhrj.v3i2.135

Download Citation

References

  • Bakhshani NM, Amirani A, Amirifard H, Shahrakipoor M. The Effectiveness of Mindfulness-Based Stress Reduction on Perceived Pain Intensity and Quality of Life in Patients With Chronic Headache. Global Journal of Health Science 2016; 8 (4): 142-151.
  • Bendtsen L et al. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia 2014; 34:426–433.
  • Benz T, Nüssle A, Lehmann S, Gantenbein AR, Sándor PS, Elfering A, Aeschlimann AG, Angst F. Health and quality of life in patients with medication overuse headache syndrome after standardized inpatient rehabilitation A cross-sectional pilot study. Medicine 2017; 96: 47.
  • Boardman HF, Thomas E, Millson DS, et al. Psychological, sleep, lifestyle, and comorbid associations with headache. Headache 2005; 45: 657–669.
  • Craner JR, Gilliam WP, Sperry JA. Rumination, Magnification, and Helplessness: How do Different Aspects of Pain Catastrophizing Relate to Pain Severity and Functioning? The Clinical Journal of Pain 2016; DOI:10.1097/AJP.0000000000000355.
  • D’Amico D, Grazzi L, Curone M, Leonardi M, Raggi A. Cost of medication overuse headache in Italian patients at the time-point of withdrawal: A retrospective study based on real data. Neurol Sci. 2017;38:3-6.
  • Diener HC, Antonaci F, Braschinsky M, Evers S, Jensen R, Lainez M, Kristoffersen ES, Tassorelli C, Ryliskiene K, Petersen JA. European Academy of Neurology guideline on the management of medication-overuse headache. European Journal of Neurology 2020, 0: 1–15doi:10.1111/ene.14268
  • Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trondelag Health Studies. Pain 2012; 153: 56–61.
  • Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders. Cephalalgia 38(1):1–211 (3rd edn)
  • Kristoffersen ES, Straand J, Russell MB, Lundqvist C. Disability, anxiety and depression in patients with medication-overuse headache in primary care – the BIMOH study. European Journal of Neurology 2015, 23 (Suppl. 1): 28–35.
  • Ljubisavljevic M, Ignjatovic A, Djordjevic V, Hadzi Pesic M, Ljubisavljevic S. Depression, Anxiety, Stress and Health Related Quality of Life among Patients with Medication Overuse Headache in Tertiary Headache Center: A Cross Sectional Study. Journal of Neuropsychiatry and Clinical Neurosciences 2021; doi: 10.1176/appi.neuropsych.20070189
  • Ljubisavljevic M, Ignjatovic A, Ljubisavljevic S. The ruminative thought style with associated anxiety influences the occurrence of medication overuse headache. Journal of Clinical Neurology 2021; https://doi.org/10.3988/jcn.2021.17.1.xx
  • Massey EK, Garnefski N, Gebhardt WA, van der Leeden R. A daily diary study on the independent and interactive effects of headache and self-regulatory factors on daily affect among adolescents. British Journal of Health Psychology 2011; 16: 288–299.
  • Mbewe E, Zairemthiama P, Yeh H, Paul R, Birbeck G, Steiner T. The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. J Headache Pain 2015; 16: 515.
  • McCracken LM, Barker E, Chilcot J. Decentering, rumination, cognitive defusion, and psychological flexibility in people with chronic pain. J Behav Med 2014; DOI 10.1007/s10865-014-9570-9.
  • ProQolid Patient-Reported Outcome and Quality of Life Instruments Database SF-36 Health Survey Serbian version. Available from: https://eprovide.mapi-trust.org/about/about-proqolid.
  • Radat F, Creac’h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, Henry P. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005; 25: 519–522.
  • Raggi A, Leonardi M, Sansone E, Curone M, Grazzi L, D’Amico D. The cost and the value of treatment of medication overuse headache in Italy: A longitudinal study based on patient-derived data. Eur J Neurol. 2020;27:62.
  • Rogers AH, Bakhshaie J, Ditre JW, Manning K, Mayorga NA, Viana AG, Zvolensky MJ. Worry and rumination: Explanatory roles in the relation between pain and anxiety and depressive symptoms among college students with pain, Journal of American College Health 2019: 67:3, 275-282.
  • SF-36 Health survey (original version) language recalls. Available from: http://www.qualitymetric.com.
  • Shabani M, Nejat H, Saffarian MR. Comparison of the effectiveness of mindfulness-based cognitive therapy and a quality of life-based therapy on rumination in patients with migraine. Int J Basic Sci Med. 2019; 4(2): 61- 68.
  • Steiner T, Stovner L, Katsarava Z, Lainez J, Lampl C, Lantéri-Minet M. et al. The impact of headache in Europe: principal results of the Euro light project. J Headache Pain 2014; 15: 31.
  • Thomsen DK, Mehlsen MY, Olesen F, Hokland M, Viidik A, Avlund K, Zachariae R. Is There an Association Between Rumination and Self-Reported Physical Health? A One-Year Follow-Up in a Young and an Elderly Sample. Journal of Behavioral Medicine 2004; 27 (3): 215-231.
  • Westergaard M, Glümer C, Hansen E, Jensen R. Prevalence of chronic headache with and without medication overuse: Associations with socioeconomic position and physical and mental health status. Pain 2014; 155: 2005–2013.
  • Westergaard M, Hansen E, Glumer C, Olesen J, Jensen R. Definitions of medicationoveruse headache in population-based studies and their implications on prevalence estimates: A systematic review. Cephalalgia 2014; 34: 409–425.
  • Westergaard ML, Munksgaard SB, Bendtsen L, Jensen RH. Medication-overuse headache: a perspective review. Therapeutic Advances in Drug Safety. 2016; 7(4): 147–158.
  • Zebenholzer K, Thamer M, Wober C. Quality of Life, Depression, and Anxiety 6 Months After Inpatient Withdrawal in Patients With Medication Overuse Headache An Observational Study. Clin J Pain 2012; 28: 284–290.
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information